用于肝细胞癌监测的简化MRI:系统综述与Meta分析
该系统综述与Meta分析纳入27项研究,评估非增强简化MRI(NC-aMRI)与增强简化MRI(CE-aMRI)监测肝细胞癌的诊断效能。汇总敏感度86%、特异度92%;NC-aMRI敏感度83%、特异度91%,CE-aMRI敏感度88%、特异度94%,两者差异无统计学意义。NC-aMRI可能有效用于肝细胞癌监测,尤其在慢性乙型肝炎高流行地区。
要点
- 简化MRI监测肝细胞癌汇总敏感度86%、特异度92%。
- NC-aMRI敏感度83%、特异度91%,CE-aMRI敏感度88%、特异度94%,差异无统计学意义。
- NC-aMRI在慢性乙型肝炎高流行区敏感度87% vs 78%(p=0.003)。
核心结论
- 监测用简化MRI方案对肝细胞癌检测表现出满意效能;NC-aMRI可能有效用于肝细胞癌监测,尤其在慢性乙型肝炎高流行地区。
研究设计与样本
- 系统综述与Meta分析,检索5个数据库,纳入27项研究(2009-2023年),其中西方国家14项、东方国家13项;采用随机效应模型汇总敏感度与特异度,并按研究地区、肝硬化及肝细胞癌患者比例、基础肝病进行亚组分析与Meta回归。
诊断标准与关键数值
- 全部研究汇总敏感度86%(95%CI 83-88%,I²=63%)、特异度92%(95%CI 90-94%,I²=74%)。21项NC-aMRI研究汇总敏感度83%(95%CI 79-87%,I²=63%)、特异度91%(95%CI 88-93%,I²=67%)。15项CE-aMRI研究汇总敏感度88%(95%CI 84-91%,I²=64%)、特异度94%(95%CI 90-96%,I²=78%)。NC-aMRI与CE-aMRI敏感度差异无统计学意义(p=0.078),特异度差异无统计学意义(p=0.157)。NC-aMRI亚组分析:慢性乙型肝炎高流行区敏感度87% vs 78%(p=0.003);东方国家研究敏感度86% vs 76%(p=0.018);慢性丙型肝炎高流行区特异度94% vs 90%(p=0.009)。Meta回归显示研究异质性主要来源为纳入多数慢性乙型肝炎患者(p=0.008)和研究地理区域(p=0.030)。
临床应用与阅片要点
- 作者认为NC-aMRI可能有效用于肝细胞癌监测,尤其在慢性乙型肝炎高流行地区;原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Given the limited sensitivity of ultrasound in hepatocellular carcinoma (HCC) surveillance, this systematic review and meta-analysis were aimed to assess the diagnostic performance of non-contrast abbreviated MRI (NC-aMRI) compared to contrast-enhanced abbreviated MRI (CE-aMRI) for HCC surveillance, offering evidence-based guidance for clinical decision-making.
METHODS: A comprehensive search was conducted across five databases, identifying studies on aMRI for HCC surveillance. The pooled sensitivity and specificity were estimated using a random effects model. Subgroup analyses and meta-regression were performed by study location, proportion of patients with cirrhosis and HCC, and underlying liver diseases.
RESULTS: The meta-analysis included 27 studies (2009-2023), distributed between Western (n = 14) and Eastern (n = 13) countries. The pooled sensitivity and specificity (95%CI, I2) were 86% (83-88%, 63%) and 92% (90%-94%, 74%). The NC-aMRI protocols reported in 21 studies exhibited 83% (79-87%, 63%) sensitivity and 91% (88-93%, 67%) specificity, while the 15 studies on CE-aMRI protocols displayed 88% (84-91%, 64%) sensitivity and 94% (90-96%, 78%) specificity, with no statistically significant differences in sensitivity (p = 0.078) or specificity (p = 0.157). Subgroup analysis in NC-aMRI studies showed significant differences in sensitivity for high-prevalent chronic hepatitis B (87% vs. 78%, p = 0.003) and studies done in eastern countries (86% vs. 76%, p = 0.018). Additionally, specificity showed significant differences for high-prevalent chronic hepatitis C (94% vs. 90%, p = 0.009), with meta-regression identifying major sources of study heterogeneity as the inclusion of a majority of patients with chronic hepatitis B (p = 0.008) and the geographic regions where studies were conducted (p = 0.030).
CONCLUSION: Surveillance aMRI protocols exhibit satisfactory performance for detecting HCC. NC-aMRI may be used effectively for HCC surveillance, especially in chronic hepatitis B prevalent settings.
引用
- Maung ST, Deepan N, Decharatanachart P, et al. Abbreviated MRI for Hepatocellular Carcinoma Surveillance - A Systematic Review and Meta-analysis. Acad Radiol. 2024. PMID: 38413315. doi:10.1016/j.acra.2024.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。